REGENERON PHARMACEUTICALS (RGO.DE) Stock Analyst Ratings
Europe - Frankfurt Stock Exchange - FRA:RGO - US75886F1075 - Common Stock
673.6 EUR
+0.6 (+0.09%)
ChartMill assigns a Buy % Consensus number of 81% to RGO.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 669.21. This target is -0.65% below the current price.
RGO.DE was analyzed by 34 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about RGO.DE.
In the previous month the buy percentage consensus was at a similar level.
RGO.DE was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-08-06 | Oppenheimer | Maintains | Outperform |
| 2021-08-06 | SVB Leerink | Maintains | Outperform |
| 2021-08-06 | Barclays | Maintains | Overweight |
| 2021-08-02 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-08 | Benchmark | Maintains | Buy |
| 2021-06-29 | HC Wainwright & Co. | Initiate | Buy |
| 2021-05-07 | SVB Leerink | Maintains | Outperform |
| 2021-05-07 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-04-19 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-03-26 | SVB Leerink | Maintains | Outperform |
| 2021-02-23 | Credit Suisse | Maintains | Outperform |
| 2021-02-16 | Cantor Fitzgerald | Maintains | Overweight |
| 2021-02-08 | SVB Leerink | Maintains | Outperform |
| 2021-02-08 | Cowen & Co. | Maintains | Outperform |
| 2021-02-08 | Credit Suisse | Maintains | Outperform |
| 2021-02-08 | Morgan Stanley | Maintains | Equal-Weight |
REGENERON PHARMACEUTICALS / RGO.DE FAQ
What do analysts expect the price target to be for REGENERON PHARMACEUTICALS (RGO.DE)?
34 analysts have analysed RGO.DE and the average price target is 669.21 EUR. This implies a price decrease of -0.65% is expected in the next year compared to the current price of 673.6.
Can you provide the consensus rating for REGENERON PHARMACEUTICALS stock?
The consensus rating for REGENERON PHARMACEUTICALS (RGO.DE) is 80.5882 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for RGO stock?
The number of analysts covering REGENERON PHARMACEUTICALS (RGO.DE) is 34.